Icagen.

Icagen, a drug-development company, was acquired by San Diego's Ligand Pharmaceuticals for $15 million. The firm will continue its local operations, and Icagen shareholders could receive payouts for hitting revenue targets. Partner Roche, a Switzerland-based...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT